CytRx - 30 Year Stock Price History | CYTR
Historical daily share price chart and data for CytRx since 1989 adjusted for splits. The latest closing stock price for CytRx as of June 03, 2019 is 0.31.
- The all-time high CytRx stock closing price was 1868.91 on January 15, 1992.
- The CytRx 52-week high stock price is 0.00, which is -100% above the current share price.
- The CytRx 52-week low stock price is 0.00, which is 100% below the current share price.
- The average CytRx stock price for the last 52 weeks is NaN.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| CytRx Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2019 |
0.6009 |
0.5150 |
0.7601 |
0.3100 |
0.3100 |
-30.93% |
| 2018 |
1.2648 |
1.7500 |
2.2700 |
0.3600 |
0.4488 |
-73.44% |
| 2017 |
2.8498 |
2.3161 |
5.7978 |
1.6900 |
1.6900 |
-24.31% |
| 2016 |
9.4273 |
15.3569 |
20.9358 |
2.2328 |
2.2328 |
-85.95% |
| 2015 |
19.4153 |
16.6767 |
31.6137 |
12.1776 |
15.8968 |
-3.28% |
| 2014 |
23.2619 |
41.3917 |
48.4703 |
12.8974 |
16.4367 |
-56.30% |
| 2013 |
15.3510 |
11.2777 |
37.6125 |
11.2178 |
37.6125 |
235.29% |
| 2012 |
18.3395 |
11.1370 |
32.5735 |
9.7780 |
11.2178 |
-4.56% |
| 2011 |
26.1511 |
44.0780 |
44.0780 |
10.7088 |
11.7541 |
-72.28% |
| 2010 |
41.0430 |
45.3373 |
59.1904 |
27.7061 |
42.3988 |
-9.82% |
| 2009 |
30.9073 |
12.5895 |
54.1529 |
10.0834 |
47.0165 |
273.33% |
| 2008 |
38.5034 |
109.9850 |
109.9850 |
10.4948 |
12.5937 |
-89.44% |
| 2007 |
152.6642 |
78.9205 |
216.1919 |
75.5622 |
119.2204 |
48.69% |
| 2006 |
61.1262 |
42.8186 |
94.0330 |
39.4603 |
80.1799 |
85.44% |
| 2005 |
44.0439 |
57.9310 |
73.0435 |
31.9040 |
43.2384 |
-26.43% |
| 2004 |
62.7751 |
80.1799 |
94.4528 |
39.4603 |
58.7706 |
-24.73% |
| 2003 |
67.9707 |
11.3343 |
132.2339 |
9.2354 |
78.0810 |
644.00% |
| 2002 |
24.6686 |
27.2864 |
44.0780 |
9.2354 |
10.4948 |
-61.54% |
| 2001 |
36.6581 |
34.1079 |
49.5352 |
21.8291 |
27.2864 |
-9.57% |
| 2000 |
62.9122 |
44.4977 |
262.3688 |
23.5082 |
30.1745 |
-20.69% |
| 1999 |
101.6528 |
44.6237 |
141.6792 |
34.1079 |
38.0456 |
-6.45% |
| 1998 |
84.5886 |
141.6792 |
152.1739 |
31.4843 |
40.6693 |
-67.03% |
| 1997 |
168.7556 |
139.0765 |
236.1319 |
123.3343 |
123.3343 |
-14.59% |
| 1996 |
179.1622 |
199.8201 |
241.3793 |
138.9505 |
144.4078 |
-23.56% |
| 1995 |
323.8014 |
230.8845 |
524.7376 |
152.1319 |
188.9055 |
-14.32% |
| 1994 |
749.6018 |
1049.4752 |
1322.3388 |
215.1004 |
220.4737 |
-78.99% |
| 1993 |
834.3164 |
902.5487 |
1165.0014 |
566.7166 |
1049.4752 |
19.05% |
| 1992 |
1015.8087 |
1007.4962 |
1868.9054 |
587.7061 |
881.5592 |
-11.59% |
| 1991 |
419.7196 |
136.4318 |
1081.0434 |
136.4318 |
997.0854 |
660.02% |
| 1990 |
333.0342 |
320.0480 |
598.2848 |
131.1928 |
131.1928 |
-54.58% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.006B |
$0.000B |
|
CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.
|
